Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that shareholders have approved the company's resolution to issue common shares in the company in connection with the proposed acquisition of Novamind Inc.
Novamind shareholders have also voted to approve the acquisition of Novamind by Numinus, under a plan of arrangement, at a separate meeting of Novamind shareholders held on Wednesday, June 8, 2022.
"We are pleased with the overwhelming support of both Numinus and Novamind shareholders for this significant and transformational transaction. This acquisition will position our business as one of the leading integrated mental wellness companies in North America offering Ketamine- and psychedelic-assisted therapies, with 13 wellness clinics, four clinical research sites and a dedicated psychedelics research laboratory," said Payton Nyquvest, founder & CEO of Numinus in a statement.
READ: Numinus Wellness granted Health Canada approval for therapy using psilocybin for patient with treatment-resistant depression
"We look forward to completing the acquisition soon and working closely with the Novamind team to share best practices and grow our collective mental health and wellness service offering.," he added.
At the special meeting of shareholders of the company, an ordinary resolution authorizing and approving the issuance of up to 63,010,034 common shares of the company to the security holders of Novamind was approved by 98.71% of the votes cast by shareholders. A total of 32,679,640 common shares of the company were voted at the meeting online or by proxy, representing approximately 15.68% of the issued and outstanding common shares of the company as of the meeting record date.
Completion of the transaction remains conditional upon approval of the Supreme Court of British Columbia and certain other customary closing conditions. The application for the final order from the Court is scheduled to be heard on June 10, 2022.
Assuming that all conditions to closing are satisfied or waived, the transaction is expected to be completed on or about June 10, 2022.
Contact the author at jon.hopkins@proactiveinvestors.com